GlassScriptPhysician profile
Liyang Tang
NPI 1124418546
$5,081.37
in general payments reported to CMS, 2019-2025
10 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $426 · 2023: $407 · 2024: $3,960 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,141 · Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,140.96 |
| Food and Beverage | $1,014.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,658.07 | 2024 | |
| Stryker Corporation | $426.04 | 2021 | |
| Inspire Medical Systems, INC. | $267.98 | 2023-2025 | Inspire |
| Coherus Oncology, INC. | $142.01 | 2024 | |
| Acclarent, INC | $136.91 | 2023 | Trudi Nav Cable, Relieva Spinplus, Acclarent Aera |
| Vertex Pharmaceuticals Incorporated | $121.83 | 2025 | |
| Baxter Healthcare | $105.27 | 2023 | |
| Axogen | $95.30 | 2023 | Avance Nerve Graft |
| Acera Surgical, INC. | $89.26 | 2024 | Restrata Wound Matrix |
| Medtronic, INC. | $38.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liyang Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.